Abstract
An analysis of survival time of 57 West European patients with hepatocellular carcinoma was carried out to define which of several possible factors (age, sex, cirrhosis and raised serum alpha-foetoprotein (AFP)) influenced survival. Although survival was significantly longer in younger patients (P less than 0.02) and in patients with normal serum AFP (P less than 0.01), multivariate analysis showed that significant variation in survival time is better explained by the single factor, the presence of cirrhosis, than by AFP level. This does not seem to apply for patients with this tumour in Africa and the Far East, and there may be a fundamental difference in the natural history of the tumour between high- and low-incidence areas.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Johnson, P., Melia, W., Palmer, M. et al. Relationship between serum alpha-foetoprotein, cirrhosis and survival in hepatocellular carcinoma. Br J Cancer 44, 502–505 (1981). https://doi.org/10.1038/bjc.1981.218
Issue Date:
DOI: https://doi.org/10.1038/bjc.1981.218
This article is cited by
-
Clinical significance of serum miR-768-3p in HBV-related hepatocellular carcinoma and its potential mechanism
Clinical and Experimental Medicine (2020)
-
Upregulation of MicroRNA-19b predicts good prognosis in patients with hepatocellular carcinoma presenting with vascular invasion or multifocal disease
BMC Cancer (2015)
-
microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma
Diagnostic Pathology (2015)
-
MicroRNA122 is a key regulator of α-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma
Nature Communications (2011)
-
Alpha-1-acid glycoprotein as potential biomarker for alpha-fetoprotein-low hepatocellular carcinoma
BMC Research Notes (2010)